Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. - Wikidata - wikimedia - TriplyDB

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

http://www.wikidata.org/entity/Q33374386

about

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura Advances in Diagnosis and Treatments for Immune Thrombocytopenia Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents.Pathophysiology and therapeutic options in primary immune thrombocytopenia.Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.Defective regulatory B-cell compartment in patients with immune thrombocytopenia CD16+ monocytes control T-cell subset development in immune thrombocytopenia.Positioning new treatments in the management of immune thrombocytopenia The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia.Immune dysregulation in immune thrombocytopenia.Elevated NKT cell levels in adults with severe chronic immune thrombocytopenia.Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.Novel treatments for immune thrombocytopenia.In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia.Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study.Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura Atopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children: A nationwide population-based cohort study.Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.Immune Thrombocytopenia in a Child with T Cell Lymphoblastic Lymphoma.Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia.Platelets in the pathogenesis of acute respiratory distress syndrome Elevated expression of interleukin-21 and its correlation to T-cell subpopulation in patients with ulcerative colitis.Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab.Assessment of regulatory T cells in childhood immune thrombocytopenic purpura.Restoration of T cell tolerance in primary ITP.Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency.Percentage of Memory B Lymphocytes and Regulatory T Lymphocytes in Peripheral Blood are Low but Not Predictive of Therapy outcomes in Newly Diagnosed Adult Patients with Primary Immune Thrombocytopenia.Pathogenesis-oriented approaches for the management of corticosteroid-resistant or relapsedprimary immune thrombocytopenia.Emerging Concepts in Immune Thrombocytopenia.

P2860

Q24645016-EF0AA473-2D95-4A10-8335-CC1437401A9E Q26738630-9EE32E81-16A8-47FD-AE8F-E1A96B4D10D4 Q28066579-ACBC69BB-B892-419C-A4AB-3EF4F65AD3C3 Q28068881-98EAC851-0AD4-4ED8-9EFC-96F454FE88FF Q30244926-B6F9CCB5-FF6B-4D7F-B331-00B0B44D2409 Q33376201-028DDF58-56E4-47AE-9024-C5E67BEB9351 Q33391221-198477F5-F6F9-46C1-9DC6-0E6490778E2E Q33393732-BC1D0BF6-BEB7-4DB1-BA0A-6C459F0BEB1B Q33396902-8DE5F4C7-B96C-4ACE-B3B8-0B4D7ED7DC8C Q33402659-B764F0AC-C6F0-4C0E-807E-C5A2CCC9F472 Q33402944-5354A4B9-D655-45DF-8E1C-A739C083DEA0 Q33404095-FFC24DCF-84E0-4DE8-9000-97456A3BE087 Q33404758-A85B37CD-8B16-4216-A8C7-64481A3C22DB Q33407649-A4440950-6339-4F64-A114-B77B7ADBD538 Q33412177-29BF952D-ADDC-4ACC-97FD-B8F256C3E5CE Q33412264-D62ACF78-2B78-4982-8E6C-B63DC912029E Q33414132-7344CC12-171A-452F-BAB3-22E2F194FDB9 Q33417826-ADDB6BB8-CA0E-4E8B-B48C-B229027962A0 Q33423336-DF5BD074-ADED-4D4E-BCD6-BB0577036E5F Q33430065-EBF3FAA3-71A2-4D4E-AD4E-67E4BAD0FDDF Q33431535-87929FEC-0D95-45A2-8E52-288593FAC2B6 Q33432419-9828E9B4-45DE-4D5F-ABEE-110F56283D67 Q33434063-AC0E94B3-5785-4BC4-9728-53E24ABFD964 Q33434245-AE8C803B-6DF6-4A57-89BA-DB0A4E55F8DE Q33435581-B66859CC-13CF-445D-90C6-8F3DFD79673F Q33439412-263594A4-CED5-462D-85CE-1CB076306305 Q33439544-B30F9254-9194-402C-BEE8-AA2678E43702 Q36237204-5E2119BF-D571-44EF-A66F-3FBE00650F5B Q36305622-B33970FF-A77F-4407-8F4B-FB8ACD93DBAC Q36399264-8EA5725E-D53D-4477-B941-EFC3609C6ADB Q42272218-FCF09F98-C572-49C6-BCD0-A802E5A7DF2C Q45764175-8DCD7D2D-FFE4-4197-9E96-C22FBDFEBD63 Q47812114-79F99AD7-104E-4FF6-9DA0-DA30EE408CD5 Q50092899-CF83DA83-7C64-4B28-9414-3B11C9896C33 Q52695218-88018BB0-36E6-4654-8B23-BB65D572A8BF Q54211951-B827C664-F233-4959-8252-38D854EA55A8

P2860

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

http://www.wikidata.org/entity/Q33374386

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@ast

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@en

type

label

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@ast

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@en

prefLabel

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@ast

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@en

P1433

Q33374386-E41CA84A-0764-4176-904E-E1571FD18C6C

P1476

Q33374386-4475A1EC-048A-49DC-96B0-574A8CE1202C

P2093

Q33374386-1C042A6E-6ED3-4455-8E72-0F487D62DBCC

Q33374386-416A2291-BA80-4DFE-8216-2F0F4079EB30

Q33374386-446F065E-2C3E-4E36-B155-5427FE9BDEDA

Q33374386-51296C7F-F4A8-4FCF-A4EB-BC9826EE2F0B

Q33374386-77110504-CFDB-42BA-AFCC-89D1097E2F51

Q33374386-8C4459F1-61DF-4BBE-828D-97629953A449

Q33374386-B6397CD0-4481-47F6-8DE9-07191F9D7543

Q33374386-C610B65F-E1ED-46B1-9D44-47AEBE523802

P2860

Q33374386-0FFB3C41-091F-4A8E-9056-38D855983127

Q33374386-12006742-7841-43DD-A40E-907C02395A02

Q33374386-3439F008-DA6B-44E5-81EA-6B2430565A34

Q33374386-463D8FEC-F24E-439C-A8BE-5BA398AB4DD7

Q33374386-4A230FED-EDBD-4DFF-87C6-6FF0AE90EBC6

Q33374386-5ACBEFED-E289-4E61-BBA1-DD96FEF30386

Q33374386-61A19530-EBBB-489A-A267-0D78B5183063

Q33374386-65A11F8D-5E47-4CC0-A3EA-82FA6CECD194

Q33374386-6669B95E-C0AF-49E8-8FFC-EC846437E026

Q33374386-946FAF6F-7B34-41DE-BCBF-5E1A00052643

P304

Q33374386-5030C796-9E25-44D2-974C-70B78AC42602

P31

Q33374386-A76D9BD1-7BE8-4810-B2A2-16D3DDF57FD6

P356

Q33374386-DF1CCC11-0D95-4CB0-8A0D-6CE58F3A6B49

P433

Q33374386-8F6D14C2-6761-4064-BF0B-EF1F04F59698

P478

Q33374386-88638309-A72B-4D64-9DED-2329C254F05C

P50

Q33374386-84A9728F-6E5F-44DD-A414-CF5CC096197B

P577

Q33374386-9C7DC25A-FDC2-48DC-82F8-06DC652350F2

P5875

Q33374386-6D68F3A9-6A15-4658-AF36-8E927480632A

P698

Q33374386-027B419E-1FA5-49ED-9A06-391AE50E3BCB

P921

Q33374386-3281C8F7-16DD-4B1D-A9C2-70D8FC15130A

P356

J.1600-0609.2006.00780.X

P1433

European Journal of Haematology

P1476

Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Dongsheng Gu

http://www.w3.org/2001/XMLSchema#string

Hairong Jia

http://www.w3.org/2001/XMLSchema#string

Hui Zhao

http://www.w3.org/2001/XMLSchema#string

Man-Chiu Poon

http://www.w3.org/2001/XMLSchema#string

Maoqiang Xu

http://www.w3.org/2001/XMLSchema#string

Renchi Yang

http://www.w3.org/2001/XMLSchema#string

Zhibo Han

http://www.w3.org/2001/XMLSchema#string

P2860

Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells

Reduced transforming growth factor-beta1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura.

Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura.

Immune pathophysiology of autoimmune thrombocytopenic purpura.

Immune thrombocytopenic purpura.

Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update.

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response.

Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.

The regulatory T cell family: distinct subsets and their interrelations.

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

P304

139-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0609.2006.00780.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6477307

http://www.w3.org/2001/XMLSchema#string

P698

17328716

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia